Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery
Authors:
- Xue-Nong ZhangXZXue-Nong Zhang
- 1 April 2010
- journal article
- research article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 6 (2) , 371-381
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Formulation and characterization of amphotericin B–chitosan–dextran sulfate nanoparticlesInternational Journal of Pharmaceutics, 2007
- Novel polymeric microspheres containing norcantharidin for chemoembolizationJournal of Controlled Release, 2006
- Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimeticJournal of Controlled Release, 2005
- Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinateInternational Journal of Pharmaceutics, 2005
- The aggregation of pig articular chondrocyte and synthesis of extracellular matrix by a lactose-modified chitosanBiomaterials, 2005
- Conjugates of Nucleoside Analogs with Lactosaminated Human Albumin to Selectively Increase the Drug Levels in Liver Blood: Requirements for a Regional ChemotherapyThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Silyl Linker-based Approach to the Solid-phase Synthesis of Fmoc Glycopeptide ThioestersBioscience, Biotechnology, and Biochemistry, 2002
- Effect of drug release rate on bioavailability of different aspirin tabletsInternational Journal of Pharmaceutics, 1996
- Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cellsEuropean Journal of Cancer, 1995
- Arabinogalactan for Hepatic Drug DeliveryBioconjugate Chemistry, 1994